Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New insights into the treatment of obesity.
Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. Blüher M, et al. Among authors: giorgino f. Diabetes Obes Metab. 2023 Aug;25(8):2058-2072. doi: 10.1111/dom.15077. Epub 2023 May 5. Diabetes Obes Metab. 2023. PMID: 37055715 Review.
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts.
Baviera M, Genovese S, Lepore V, Colacioppo P, Robusto F, Tettamanti M, D'Ettorre A, Avanzini F, Fortino I, Nicolucci A, Roncaglioni MC, Giorgino F. Baviera M, et al. Among authors: giorgino f. Diabetes Obes Metab. 2021 Jul;23(7):1484-1495. doi: 10.1111/dom.14361. Epub 2021 Mar 15. Diabetes Obes Metab. 2021. PMID: 33606897
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Schnell O, Cos X, Cosentino F, Forst T, Giorgino F, Heersprink HJL, Kosiborod M, Wanner C, Standl E. Schnell O, et al. Among authors: giorgino f. Cardiovasc Diabetol. 2021 Mar 31;20(1):75. doi: 10.1186/s12933-021-01254-1. Cardiovasc Diabetol. 2021. PMID: 33789663 Free PMC article.
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Schnell O, Battelino T, Bergenstal R, Blüher M, Böhm M, Brosius F, Carr RD, Ceriello A, Forst T, Giorgino F, Guerci B, Heerspink HJL, Itzhak B, Ji L, Kosiborod M, Lalić N, Lehrke M, Marx N, Nauck M, Rodbard HW, Rosano GMC, Rossing P, Rydén L, Santilli F, Schumm-Draeger PM, Vandvik PO, Vilsbøll T, Wanner C, Wysham C, Standl E. Schnell O, et al. Among authors: giorgino f. Cardiovasc Diabetol. 2022 Apr 8;21(1):50. doi: 10.1186/s12933-022-01481-0. Cardiovasc Diabetol. 2022. PMID: 35395808 Free PMC article.
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial.
Piemonti L, Keymeulen B, Gillard P, Linn T, Bosi E, Rose L, Pozzilli P, Giorgino F, Cossu E, Daffonchio L, Goisis G, Ruffini PA, Maurizi AR, Mantelli F, Allegretti M. Piemonti L, et al. Among authors: giorgino f. Diabetes Obes Metab. 2022 Sep;24(9):1840-1849. doi: 10.1111/dom.14770. Epub 2022 Jul 4. Diabetes Obes Metab. 2022. PMID: 35589610 Free PMC article. Clinical Trial.
365 results